CoChat

Sleep apnoea and quality of life in growth hormone (GH)‐deficient adults before and after 6 months of GH replacement therapy

Peker, Y., Svensson, J., Hedner, J., Grote, L., Johannsson, G. · 2006 · Clinical Endocrinology
Cited by 36

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Abstract

Summary: Objective To investigate the sleep architecture and breathing as well as quality of life (QoL) in adults with GH deficiency (GHD) before and 6 months after GH replacement therapy. Design A prospective observational study. Patients Nineteen consecutive adults with GHD (11 men, eight women; mean age 53, range 21–73 years) were studied. Measurements An overnight sleep study was performed and the Minor Symptom Evaluation Profile (MSEP), Functional Outcome of Sleep Questionnaire (FOSQ), Short Form 36 (SF‐36) and Epworth Sleepiness Scale (ESS) questionnaires were applied at baseline and after the treatment period. Results For the whole group, there were no significant changes in mean total sleep time (TST; 370 min vs. 374 min), proportion of slow‐wave sleep (SWS; 17·8%vs. 18·4%) and rapid eye movement (REM) sleep (12·1%vs. 13·9%) on GH replacement. Mean apnoea–hypopnoea index (AHI) was high and remained unchanged (28·2/h before vs. 28·0/h following GH replacement). Twelve patients (63%) were found to have obstructive sleep apnoea (OSA; AHI ≥ 10/h) at baseline. Compared with GH‐deficient patients without OSA (AHI 3·9/h), the OSA patients (AHI 42·4/h) had less SWS (11·4%vs. 28·6%, P = 0·010) and REM sleep (10·1%vs. 15·5%, P = 0·036). A marginal increase was observed in REM sleep time (10·1% before vs. 12·7% after GH; P = 0·048) while SWS was unchanged in this group. Moreover, MSEP for General Well‐being and Responsiveness, FOSQ scores for General Productivity, Activity Level and Vigilance as well as SF‐36 domains for Vitality and Mental Health were improved. Conclusions Contrary to some previous observations in a smaller group of patients, our data suggest that GH therapy does not induce or aggravate OSA in GH‐deficient adults. Moreover, GH therapy may improve some of the QoL dimensions in these patients.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2265.2006.02555.x

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Cited by

See all 36

Metadata

Authors
Peker, Y., Svensson, J., Hedner, J., Grote, L., & Johannsson, G.
Venue
Clinical Endocrinology
Publisher
Wiley
Published
2006-06
Volume
65
Issue
1
Pages
98-105
ISSN
  • 0300-0664 (ISSN-L)
  • 1365-2265
OpenAlex
W2041227824
Cited by
36
References
10
FWCI
1.18
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Sleep apnoea and quality of life in growth hormone (GH)‐deficient adults before and after 6 months of GH replacement therapy. https://app.cochat.ai/papers/10.1111/j.1365-2265.2006.02555.x
The paper
Peker, Y., Svensson, J., Hedner, J., Grote, L., & Johannsson, G. (2006). Sleep apnoea and quality of life in growth hormone (GH)‐deficient adults before and after 6 months of GH replacement therapy. Clinical Endocrinology. https://doi.org/10.1111/j.1365-2265.2006.02555.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.